Home › Research › Biomarkers
Diagnosis of cognitive impairment and dementia: blood plasma and optical coherence tomography
Jali V, Zhang Q, Chong JR, Wong D, Tan B, Garhöfer G, Hilal S, Lai MKP et al.. Brain communications, 2024-12-27
Topic: Risk, prevention and care in population studies
Plain-language summary
After adjusting for retinal scan signal strength, neurofilament light chain showed a stronger negative association with retinal nerve fibre layer thickness [standardized beta estimate ( β ) = -0.184] and ganglion cell-inner plexiform layer thickness ( β = -0.139) compared to phosphorylated tau181, which exhibited weaker associations with ganglion cell-inner plexiform layer ( β = -0.091) and retinal nerve fibre layer ( β = -0.059). While retinal parameters provided modest discriminatory ability (AUC = 0.60), plasma biomarkers demonstrated superior diagnostic performance (AUC = 0.76). These findings underscore the potential of plasma biomarkers, particularly neurofilament light chain, for the early detection of dementia.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Jali, V., Zhang, Q., Chong, JR., Wong, D., Tan, B., Garhöfer, G., et al. (2025). Diagnosis of cognitive impairment and dementia: blood plasma and optical coherence tomography. Brain communications. https://doi.org/10.1093/braincomms/fcae472
Vancouver
Jali V, Zhang Q, Chong JR, Wong D, Tan B, Garhöfer G, et al. Diagnosis of cognitive impairment and dementia: blood plasma and optical coherence tomography. Brain communications. 2025. doi:10.1093/braincomms/fcae472. PMID: 39749011.
BibTeX
@article{jali2025-39749011,
author = {Jali, V. and Zhang, Q. and Chong, JR. and Wong, D. and Tan, B. and Garhöfer, G. and Hilal, S. and Lai, M. K. P. and others},
title = {{Diagnosis of cognitive impairment and dementia: blood plasma and optical coherence tomography}},
journal = {Brain communications},
year = {2025},
doi = {10.1093/braincomms/fcae472},
pmid = {39749011},
url = {https://doi.org/10.1093/braincomms/fcae472}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- After adjusting for retinal scan signal strength, neurofilament light chain showed a stronger negative association with retinal nerve fibre layer thickness [standardized beta estimate ( β ) = -0.184] and ganglion cell-inner plexiform layer thickness ( β = -0.139) compared to phosphorylated tau181, which exhibited weaker associations with ganglion cell-inner plexiform layer ( β = -0.091) and retinal nerve fibre layer ( β = -0.059).
- While retinal parameters provided modest discriminatory ability (AUC = 0.60), plasma biomarkers demonstrated superior diagnostic performance (AUC = 0.76).
- These findings underscore the potential of plasma biomarkers, particularly neurofilament light chain, for the early detection of dementia.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designcross-sectional
- Participants100
- Effect sizeAUC = 0.60; AUC = 0.76
- Evidence strengthLow
How this study scored 69/100
Published in a leading specialty journal, and it is a snapshot of people at one point in time. Scored zero for randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 40 of the 58 points we could judge it on, which is 69 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Brain communications) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 4 / 12 | A snapshot of people at one point in time |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 100 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39749011) |
| Free to read | 2 / 2 | Free to read |
| Points | 40 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 40 of the 58 points we could judge it on is 69 out of 100. |
| Total | 69 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.